GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Viral oncoprotein targeted immune therapy for Merkel cell carcinoma

$637,515
Paul Nghiem · University Of Washington · R01 · FY2015 · CA

Dissecting the Kaposi Sarcoma Tumor Microenvironment at the Single Cell Level

$637,486
Warren Phipps · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA

UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center

$637,440
Jason Derek Merker · Univ Of North Carolina Chapel Hill · UG1 · FY2024 · CA

HLA-E and NKG2A define a novel immune checkpoint axis in non-muscle-invasive bladder cancer

$637,395
Amir Horowitz · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA

High Content Representation and Association of 3D Cell Culture Models

$637,355
Bahram A. Parvin · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2011 · CA

The impact of interstitial fluid flow on CAR T cell trafficking, distribution, and efficacy

$637,292
Jennifer M Munson · Virginia Polytechnic Inst And St Univ · R01 · FY2024 · NS

FAST-FNA immune cell profiling in HNSCC

$637,189
Ralph Weissleder · Massachusetts General Hospital · R01 · FY2024 · CA

The role of tumor-macrophage hybrid cells in prostate cancer metastasis

$637,168
Tim H.-M. Huang · University Of Texas Hlth Science Center · U01 · FY2024 · CA

The role of tumor-macrophage hybrid cells in prostate cancer metastasis

$637,168
Tim H.-M. Huang · University Of Texas Hlth Science Center · U01 · FY2025 · CA

"Novel Mouse Models for Quantitative Understanding of Baseline and Therapy-Driven Evolution of Prostate Cancer Metastasis"

$637,090
Dawid Grzegorz Nowak · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA

Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer

$637,054
Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA

PET-EPRI

$636,938
Raymond Robert Raylman · West Virginia University · R01 · FY2018 · EB

The Epidemiology of Immune Responses in Colorectal Cancer

$636,888
Stephen B Gruber · University Of Southern California · R01 · FY2018 · CA

Enhancing cell therapy for brain tumors

$636,818
Catherine Mary Bollard · Children'S Research Institute · U01 · FY2022 · CA

Enhancing cell therapy for brain tumors

$636,807
Catherine Mary Bollard · Children'S Research Institute · U01 · FY2020 · CA

Intracellular In vivo Imaging

$636,801
Peter L. Choyke · Basic Sciences · Z01 · FY2007 · CA

Enhancing cell therapy for brain tumors

$636,799
Catherine Mary Bollard · Children'S Research Institute · U01 · FY2019 · CA

Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer

$636,731
Kwok Kin Wong · New York University School Of Medicine · U01 · FY2019 · CA

Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesis

$636,722
Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2023 · CA

MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer

$636,708
Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2018 · CA

Image-guided cancer therapy using heat activatable CAR T cells

$636,703
Stanislav Y Emelianov · Georgia Institute Of Technology · R01 · FY2024 · EB

Incorporating Phase I/II drug/chemical metabolism in HTS via micro scale co-culture

$636,657
Jose Antonio Jimenez-Torres · Onexio Biosystems, Llc · R44 · FY2021 · ES

Translational Pathology Core

$636,643
Peter A Jones · University Of Southern California · P30 · FY2015 · CA

Multiscale Models of Wound Cell Plasticity for Regeneration

$636,641
Qing Nie · University Of California-Irvine · U01 · FY2021 · AR

Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)

$636,578
Ana Aparicio · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA